It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers
Cambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impact of Alzheimer's disease.
12 hours ago
0
9